Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Tonix Pharmaceuticals Holding (TNXP) Return on Equity: 2024-2025

Historic Return on Equity for Tonix Pharmaceuticals Holding (TNXP) over the last 2 years, with Sep 2025 value amounting to -0.49%.

  • Tonix Pharmaceuticals Holding's Return on Equity rose 195.00% to -0.49% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.49%, marking a year-over-year increase of 195.00%. This contributed to the annual value of -1.12% for FY2024, which is N/A change from last year.
  • According to the latest figures from Q3 2025, Tonix Pharmaceuticals Holding's Return on Equity is -0.49%, which was down 4.31% from -0.47% recorded in Q2 2025.
  • Over the past 5 years, Tonix Pharmaceuticals Holding's Return on Equity peaked at -0.47% during Q2 2025, and registered a low of -2.44% during Q3 2024.
  • Moreover, its 2-year median value for Return on Equity was -1.05% (2024), whereas its average is -1.26%.
  • Data for Tonix Pharmaceuticals Holding's Return on Equity shows a peak YoY soared of 195bps (in 2025) over the last 5 years.
  • Over the past 2 years, Tonix Pharmaceuticals Holding's Return on Equity (Quarterly) stood at -1.28% in 2024, then surged by 195bps to -0.49% in 2025.
  • Its last three reported values are -0.49% in Q3 2025, -0.47% for Q2 2025, and -0.82% during Q1 2025.